RB1 and neoplasm: Administration of a very low dosage of C3I-22 could already effectively clear the tumor burden of the transplanted DLD-1 cells and mitigate the levels of pRb and CDK4, and within the period of treatment the mice displayed no severe liver and kidney toxicity (Figure 9, J–L, and Supplemental Figure 7, I–K).